Dr. Catherine N. Le, MD

Dr. Le practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Le's NPI, 1457794364, was assigned on April 10, 2013. Dr. Le graduated from WashU Medicine in 2013. Dr. Le holds California license A141737.

Dr. Le's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Le's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Le practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Le's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Le is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Le's licenses on file in 2 states: California and Tennessee.

Dmand AI lists acute skin infection, endocarditis, hiv/aids, joint or bone infection, lyme disease and pneumonia among the conditions Dr. Le treats.

CMS data shows 715 Medicare services from Dr. Le across 10 procedure codes in 2024, for 270 Medicare patients. Medicare paid $73,094 for them.

CMS counts 270 Medicare patients who saw Dr. Le in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Le's median patient age at 60, with 44% women.

In 2024, Dr. Le wrote 429 Medicare Part D claims for 75 patients. 73% of them were for generic drugs. CMS names the drug for 250 of them, across 12 drugs with 11 or more claims each, at $147,280 in total drug cost. In 2023, CMS named 133 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Le for performance year 2024, reported as part of a group. Dr. Le accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Le as offering telehealth.

Dmand AI links 5 papers to Dr. Le in 2017. 2017 was the busiest year, with 2. The most frequent topics are HIV Infections. Dr. Le's most frequent co-authors are Evan L. Brittain, MD, Rana El Feghaly, MD and Anna Ryan Hemnes, MD.

CMS Open Payments shows 39 general payments to Dr. Le from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 95% of the total. Astellas Pharma US Inc paid the most, $589.

Dmand AI lists 3 awards for Dr. Le, most recently Best New Service of the Year: Cedars Sinai COVID-19 Recovery Program in 2021.

Dr. Le graduated from WashU Medicine in 2013.

Dr. Le is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.